Study of the Efficacy, Safety and Pharmacokinetics of Pamiparib (BGB-290) in Participants With Advanced Solid Tumors

Clinical trial NCT03333915 · COMPLETED

Trial details

NCT number: NCT03333915
Sponsor: BeiGene
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced High-grade Ovarian Cancer Triple Negative Breast Cancer

Start date: 2016-12-21
Primary completion: 2020-08-24
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.